Cargando…

Traditional Chinese medicine Lingguizhugan decoction treating non-alcoholic fatty liver disease with spleen-yang deficiency pattern: Study protocol for a multicenter randomized controlled trial

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a common chronic liver disease characterized by excessive fat accumulation in the liver. One of the underlying pathophysiological mechanisms is insulin resistance (IR). Traditional Chinese medicine (TCM) has showed potential benefits in the ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Jingjuan, Wang, Ruirui, You, Shengfu, Zhang, Lei, Zheng, Peiyong, Ji, Guang, Liu, Baocheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288405/ https://www.ncbi.nlm.nih.gov/pubmed/32522273 http://dx.doi.org/10.1186/s13063-020-04362-7

Ejemplares similares

Lingguizhugan decoction improves non-alcoholic fatty liver disease by altering insulin resistance and lipid metabolism related genes: a whole trancriptome study by RNA-Seq
por: Zhu, Mingzhe, et al.
Publicado: (2017)

Evaluation of the Mechanism of Modified Lingguizhugan Decoction in the Treatment of Nonalcoholic Fatty Liver Disease
por: Yang, Fuyuan, et al.
Publicado: (2022)

Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites
por: Zhu, Mingzhe, et al.
Publicado: (2023)

Erratum to “Evaluation of the Mechanism of Modified Lingguizhugan Decoction in the Treatment of Nonalcoholic Fatty Liver Disease”
por: Yang, Fuyuan, et al.
Publicado: (2022)

Lingguizhugan Decoction Protects against High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease by Alleviating Oxidative Stress and Activating Cholesterol Secretion
por: Yang, Lili, et al.
Publicado: (2017)

Lingguizhugan decoction attenuates doxorubicin-induced heart failure in rats by improving TT-SR microstructural remodeling
por: Li, Xueping, et al.
Publicado: (2019)

Lingguizhugan decoction attenuates diet-induced obesity and hepatosteatosis via gut microbiota
por: Liu, Meng-Ting, et al.
Publicado: (2019)

Chinese Medicine Formula Lingguizhugan Decoction Improves Beta-Oxidation and Metabolism of Fatty Acid in High-Fat-Diet-Induced Rat Model of Fatty Liver Disease
por: Liu, Tao, et al.
Publicado: (2013)

Traditional Chinese medicine Lingguizhugan decoction ameliorate HFD-induced hepatic-lipid deposition in mice by inhibiting STING-mediated inflammation in macrophages
por: Cao, Lin, et al.
Publicado: (2022)

A Study on the Therapeutic Efficacy of San Zi Yang Qin Decoction for Non-Alcoholic Fatty Liver Disease and the Underlying Mechanism Based on Network Pharmacology
por: Li, Yiping, et al.
Publicado: (2021)

Lingguizhugan Decoction Targets Intestinal Microbiota and Metabolites to Reduce Insulin Resistance in High-Fat Diet Rats
por: Ning, Ying, et al.
Publicado: (2022)

Protective effects of Lingguizhugan decoction on amyloid-beta peptide (25-35)-induced cell injury: Anti-inflammatory effects☆
por: Xi, Feifei, et al.
Publicado: (2012)

Modified lingguizhugan decoction incorporated with dietary restriction and exercise ameliorates hyperglycemia, hyperlipidemia and hypertension in a rat model of the metabolic syndrome
por: Yao, Limei, et al.
Publicado: (2017)

Phytochemical Analysis Using UPLC-MS/MS Combined with Network Pharmacology Methods to Explore the Biomarkers for the Quality Control of Lingguizhugan Decoction
por: Li, Baolin, et al.
Publicado: (2021)

Effects of decoction of Angelica Sinensis, Zingiberis Rhizoma Recens, and mutton on physiology and biochemistry of Sprague Dawley female rats with spleen-kidney Yang deficiency
por: Liu, Zhiyong, et al.
Publicado: (2023)

Integrative metabolic and microbial profiling on patients with Spleen-yang-deficiency syndrome
por: Lin, Zhang, et al.
Publicado: (2018)

A New Model of Diarrhea with Spleen-Kidney Yang Deficiency Syndrome
por: Zhu, Jiajie, et al.
Publicado: (2018)

YiQi YangYin Decoction Attenuates Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Rats
por: Li, Fengjin, et al.
Publicado: (2021)

Shengjing Runchang Decoction ameliorates spleen deficiency-induced constipation in children: An observational study
por: Li, Qi, et al.
Publicado: (2022)

Development and Validation of the Quality-of-Life Assessment System for Lung Cancer Based on Traditional Chinese Medicine
por: Wan, Chonghua, et al.
Publicado: (2012)

A Retrospective Trial Exploring Erzhu Yiren Decoction in Gastric Ulcer with Spleen Deficiency and Dampness-Heat
por: Zhang, Ting, et al.
Publicado: (2022)

Effect of Danqi Buxin Decoction on Chronic Function Indexes and Life Quality in Patients with Chronic Heart Failure of Yang Deficiency Type
por: Sheng, Yunjiao, et al.
Publicado: (2021)

Yang/Qi Invigoration: An Herbal Therapy for Chronic Fatigue Syndrome with Yang Deficiency?
por: Leong, Pou Kuan, et al.
Publicado: (2015)

Simo decoction curing spleen deficiency constipation was associated with brain-bacteria-gut axis by intestinal mucosal microbiota
por: Yi, Xin, et al.
Publicado: (2023)

Efficacy and safety of Linggui Zhugan decoction in the treatment of chronic heart failure with Yang deficiency: A protocol for systematic review and meta-analysis
por: Li, Yumeng, et al.
Publicado: (2021)

The traditional Chinese formulae Ling-gui-zhu-gan decoction alleviated non-alcoholic fatty liver disease via inhibiting PPP1R3C mediated molecules
por: Dang, Yanqi, et al.
Publicado: (2019)

Studies on the Mechanism of the Volatile Oils from Caoguo-4 Decoction in Regulating Spleen Deficiency Diarrhea by Adjusting Intestinal Microbiota
por: Mei, Li, et al.
Publicado: (2022)

Systems pharmacology-based exploration reveals mechanisms of anti-steatotic effects of Jiang Zhi Granule on non-alcoholic fatty liver disease
por: Zheng, Yiyuan, et al.
Publicado: (2018)

Efficacy of modified LiuJunZi decoction on functional dyspepsia of spleen-deficiency and qi-stagnation syndrome: a randomized controlled trial
por: Zhang, Shengsheng, et al.
Publicado: (2013)

Study on Supramolecules in Traditional Chinese Medicine Decoction
por: Gao, Yuan, et al.
Publicado: (2022)

Study on the mechanism of warming yang and reducing turbidity decoction in the treatment of diabetic kidney disease based on network pharmacology
por: Cui, Quan-Qing, et al.
Publicado: (2022)

Effect of modified ShengYangYiwei decoction on painless gastroscopy and gastrointestinal and immune function in gastric cancer patients
por: Mi, Sui-Cai, et al.
Publicado: (2023)

The Th17/Treg Immune Balance in Ulcerative Colitis Patients with Two Different Chinese Syndromes: Dampness-Heat in Large Intestine and Spleen and Kidney Yang Deficiency Syndrome
por: Gong, Yang, et al.
Publicado: (2015)

Yiwei decoction promotes apoptosis of gastric cancer cells through spleen-derived exosomes
por: Chen, Yingzhi, et al.
Publicado: (2023)

Application of metabolomics in the diagnosis of non-alcoholic fatty liver disease and the treatment of traditional Chinese medicine
por: Shao, Mingmei, et al.
Publicado: (2022)

Network pharmacology reveals the multiple mechanisms of Xiaochaihu decoction in the treatment of non-alcoholic fatty liver disease
por: Hu, Qichao, et al.
Publicado: (2020)

Computation-Based Discovery of Potential Targets for Rheumatoid Arthritis and Related Molecular Screening and Mechanism Analysis of Traditional Chinese Medicine
por: Sun, Jijia, et al.
Publicado: (2022)

Shengmai Yin formula modulates the gut microbiota of spleen-deficiency rats
por: You, Yu, et al.
Publicado: (2020)

Clinical effects of a traditional Chinese medicine nursing programme to intervene in gastric pain of the spleen and stomach with Qi deficiency
por: Yu, Yin-Hong, et al.
Publicado: (2023)

Validation of the qi blood yin yang deficiency questionnaire on chronic fatigue
por: Kim, Jihye, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mkv01flcbkvapqe7h79hrk0u0n